LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel Cell Sieve Reduces Risk of Contamination During Filtration of Cell Suspensions and Primary Cell Isolates

By LabMedica International staff writers
Posted on 15 Aug 2013
Image: EASYstrainer cell sieve for filtration of cell suspensions and primary cell isolates (Photo courtesy of Greiner Bio-One).
Image: EASYstrainer cell sieve for filtration of cell suspensions and primary cell isolates (Photo courtesy of Greiner Bio-One).
A novel sterile, single-use cell sieve is ideal for preparing single cells for flow cytometry and to separate individual cells after organ digestion as part of the primary cell extraction process.

Greiner Bio-One (Kremsmuenster, Austria), a company that has focused on the development, production, and distribution of plastic laboratory products, has introduced EASYstrainer, a cell sieve for the filtration of cell suspensions.

To prevent sterile filter material from becoming contaminated through accidental contact EASYstrainer was designed with a circumferential mantle surface and handle fitted directly on the sieve. The unit is sealed in blister packaging that ensures reliable, aseptic removal of sieves from the pack.

The EASYstrainer features a venting slot between the collection tube and the attached cell sieve. Air in the tube escapes through this slot during the rapid filtration step, and overflow is avoided. This special property prevents the accumulation of filtration liquid between the sieve and tube and thus the associated risk of contamination.

EASYstrainer is suitable for all standard 50 ml tubes and is available in mesh widths of 40, 70, and 100 microliters.

Related Links:
Greiner Bio-One

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Silver Member
PCR Plates
Diamond Shell PCR Plates

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more